These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12869815)

  • 1. Nuclear medicine in the prediction and detection of radiation associated normal tissue damage of kidney, brain, bone marrow and salivary glands.
    Goethals I; Dierckx R; De Meerleer G; Gemmel F; De Neve W; Van De Wiele C
    Nucl Med Commun; 2003 Aug; 24(8):845-52. PubMed ID: 12869815
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of nuclear medicine in the prediction and detection of radiation-associated normal pulmonary and cardiac damage.
    Goethals I; Dierckx R; De Meerleer G; De Sutter J; De Winter O; De Neve W; Van de Wiele C
    J Nucl Med; 2003 Sep; 44(9):1531-9. PubMed ID: 12960203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic value of radioisotopes and thermography in salivary gland diseases.
    de Rossi G
    Radiol Diagn (Berl); 1978 Aug; 19(4):505-11. PubMed ID: 734099
    [No Abstract]   [Full Text] [Related]  

  • 4. [Scintigraphy of bone marrow for the evaluation of injuries caused by antiblastic radiotherapy].
    Coda C; Cartia GL; Ciambellotti E
    Minerva Med; 1987 Nov; 78(21):1611-5. PubMed ID: 3683958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood and bone marrow dosimetry in radioiodine therapy of thyroid cancer.
    Sgouros G
    J Nucl Med; 2005 May; 46(5):899-900; author reply 901. PubMed ID: 15872367
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH.
    Lassmann M; Hänscheid H; Reiners C; Thomas SR
    J Nucl Med; 2005 May; 46(5):900-1; author reply 901. PubMed ID: 15872369
    [No Abstract]   [Full Text] [Related]  

  • 7. How should we measure and report radiotherapy-induced xerostomia?
    Eisbruch A; Rhodus N; Rosenthal D; Murphy B; Rasch C; Sonis S; Scarantino C; Brizel D
    Semin Radiat Oncol; 2003 Jul; 13(3):226-34. PubMed ID: 12903012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [End-results of ionizing radiations in nuclear medicine].
    Gougeon B; Coradin D
    Rev Infirm; 2015 Apr; (210):49-50. PubMed ID: 26145431
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of bone-marrow scanning with technetium-99m sulfur colloid in pediatric oncology.
    Siddiqui AR; Oseas RS; Wellman HN; Doerr DR; Baehner RL
    J Nucl Med; 1979 May; 20(5):379-86. PubMed ID: 232146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevention and treatment of radiotherapy - induced xerostomia.
    Eisbruch A; Rhodus N; Rosenthal D; Murphy B; Rasch C; Sonis S; Scarantino C; Brizel D
    Semin Radiat Oncol; 2003 Jul; 13(3):302-8. PubMed ID: 12903018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioactive iodine and the salivary glands.
    Mandel SJ; Mandel L
    Thyroid; 2003 Mar; 13(3):265-71. PubMed ID: 12729475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Normal tissue tolerance to external beam radiation therapy: kidney].
    Wong Hee Kam S; Huguet F
    Cancer Radiother; 2010 Jul; 14(4-5):340-3. PubMed ID: 20466576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioprotectors: current status and new directions.
    Grdina DJ; Murley JS; Kataoka Y; Zhou D; Seed TM
    Radiat Res; 2005 Jun; 163(6):704-5. PubMed ID: 16044505
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer.
    de Keizer B; Hoekstra A; Konijnenberg MW; de Vos F; Lambert B; van Rijk PP; Lips CJ; de Klerk JM
    J Nucl Med; 2004 Sep; 45(9):1549-54. PubMed ID: 15347723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal uptake of Tc-99m methylene diphosphonate after radiation therapy.
    Wistow BW; McAfee JG; Sagerman RH; Thomas FD; Grossman ZD
    J Nucl Med; 1979 Jan; 20(1):32-4. PubMed ID: 430175
    [No Abstract]   [Full Text] [Related]  

  • 16. The radiographic expression of radiotherapeutic injury: an overview.
    Rubin P
    Semin Roentgenol; 1974 Jan; 9(1):5-13. PubMed ID: 4813632
    [No Abstract]   [Full Text] [Related]  

  • 17. 11C-methionine PET, a novel method for measuring regional salivary gland function after radiotherapy of head and neck cancer.
    Buus S; Grau C; Munk OL; Bender D; Jensen K; Keiding S
    Radiother Oncol; 2004 Dec; 73(3):289-96. PubMed ID: 15588873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary gland sparing in the treatment of head and neck cancer.
    Scrimger R
    Expert Rev Anticancer Ther; 2011 Sep; 11(9):1437-48. PubMed ID: 21929317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risks to healthy tissues from the use of existing and emerging techniques for radiation therapy.
    Ottolenghi A; Smyth V; Trott KR
    Radiat Prot Dosimetry; 2011 Feb; 143(2-4):533-5. PubMed ID: 21199824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Tower of Babel].
    Burchert W
    Nuklearmedizin; 2011; 50(2):49-51. PubMed ID: 21542196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.